In a media report released Wednesday, the European Medicines Agency (EMA) noted that the benefits of the Oxford / AstraZeneca vaccine continue to outweigh the risks and that there is no evidence to justify restricting vaccine administration to specific age groups.
Despite the conclusion, about 17 member states of the European Union have imposed restrictions on its use. Belgium is the latest country to say it will administer the vaccine only to those over 55 next month.
The UK regulator, the MHRA, has also recommended that healthy people under the age of 30 be provided with another vaccine when possible.
The UK Medicines and Drugs Regulatory Agency (MHRA), the UK regulator has recommended that healthy people under the age of 30 should get another vaccine when possible.
Meanwhile EU Health Commissioner Stella Kyriakides said in a statement that it was vital to form a common policy, given the public's shaky confidence in the AstraZeneca vaccine. She held a meeting with EMA officials and insisted that the vaccine be widely used.
"Vaccine safety has always been central to our EU vaccine strategy. "Today's assessment shows that our pharmacovigilance system works: suspected side effects are reported quickly, information is shared and our experts come together quickly to evaluate all available evidence." She said.
"Our decisions must now be based on the scientific work of the EMA, and a rigorous, ongoing assessment of the risks and rewards. "I urge health ministers today to take a coordinated approach across Europe to improve public confidence," Kyriakides added.
Burimet: Guardian, Reuters
